Moreover, ghrelin administration mimics some of the results that we obtained with GH treatment: it has proven to be effective in mitigating intestinal injury after irradiation in rats [48], promoting mucosal proliferation, reducing apoptosis in the elemental diet-induced hypotrophic intestine [62], and in the chemoprevention of inflammation-associated colorectal carcinogenesis, but without tumor-promoting effects [46]. Here, GHRL is linked to neoplasm.